XpresSpa Group Announces Partnership with United Airlines for COVID-19 Testing with XpresCheck Testing Facilities
December 17 2020 - 08:30AM
XpresSpa Group, Inc. (Nasdaq: XSPA) (“XpresSpa” or the “Company”),
a health and wellness company, today announced its XpresCheck
subsidiary had entered into a national agreement with United
Airlines to offer COVID-19 testing services starting with Newark
Liberty International Airport (EWR) and Denver International
Airport (DEN). Beginning Monday, December 21, XpresCheck will
support direct flights to Hawaii creating air bridges between more
airports and vacation destinations, so travelers can return to
safer travel during the COVID-19 pandemic.
“We are very pleased to support United’s efforts to provide
their customers with more testing options to meet their destination
entry requirements with our easy rapid molecular testing protocol
and convenient on-site testing facilities,” said Doug Satzman,
XpresSpa Group’s chief executive officer. "Our partnership with
United Airlines will start with select flights to Hawaii in two
major hub airports and expand to additional cities as our plans
continue to develop.”
XpresCheck will provide pre-travel testing on-site with rapid
molecular testing services to individuals, in order to detect the
active presence of the COVID-19 virus and reduce the risk of
spreading the virus. Passengers who are found to test positive from
a rapid test are informed that they must exit the airport and
self-isolate per CDC guidelines, along with anyone whom they are
traveling with. As more destinations mandate testing requirements,
partnerships between airport testing facilities and airlines will
continue to pave the way to restoring traveler confidence and
safety in 2021.
“United was the first to offer a customer COVID-19 testing
program and we continue to lead the way in providing greater
accessibility to more testing options,” said Toby Enqvist, chief
customer officer. “Our partnership with XpresCheck represents
another way we can continue to meet our customers’ needs and
contribute to creating the safest travel experience possible.”
About United Airlines
United's shared purpose is "Connecting People. Uniting the
World." For more information, visit united.com, follow @United
on Twitter and Instagram or connect on Facebook. The common stock
of United's parent, United Airlines Holdings, Inc., is traded on
the Nasdaq under the symbol "UAL".
About XpresSpa Group, Inc.
XpresSpa Group, Inc. (Nasdaq: XSPA) is a leading
global health and wellness holding company. XpresSpa Group’s core
asset, XpresSpa, is a leading airport retailer of spa services and
related health and wellness products, with 50 locations in 25
airports globally. Through its XpresTest, Inc. subsidiary, the
Company also provides COVID-19 screening and testing under its
XpresCheck™ brand at JFK International Airport, Newark Liberty
International Airport, and Logan International Airport. To learn
more about XpresSpa Group, visit: www.XpresSpaGroup.com. To learn
more about XpresSpa, visit www.XpresSpa.com. To learn more about
XpresCheck, visit www.XpresCheck.com.
Forward-Looking StatementsThis
press release may contain "forward-looking" statements within the
meaning of Section 27A of the Securities Act of 1933, and Section
21E of the Securities Exchange Act of 1934. These include
statements preceded by, followed by or that otherwise include the
words "believes," "expects," "anticipates," "estimates,"
"projects," "intends," "should," "seeks," "future," "continue," or
the negative of such terms, or other comparable terminology. In
particular, these statements include, without limitation,
statements about our expectations relating to our new XpresCheck™
concept, being able to expand testing to other communicable
diseases as well as administer vaccinations for the seasonal flu,
our positioning to be part of the national rollout of various
COVID-19 vaccinations as they become available, the degree to which
our public testing model assists passengers meet testing
requirements in select states and countries, our ability to
identify and gain access to the latest and best COVID-19 testing
methodologies and equipment, and our ability further expand our
initial sites and our overall ability to manage the regulatory
challenges associated with this business line.
Forward-looking statements relating to expectations about future
results or events are based upon information available to XpresSpa
Group as of today's date and are not guarantees of the future
performance of the company, and actual results may vary materially
from the results and expectations discussed. Additional information
concerning these and other risks is contained in XpresSpa Group’s
most recently filed Annual Report on Form 10-K, Quarterly Report on
Form 10-Q, recent Current Reports on Form 8-K and other Securities
and Exchange Commission filings. All subsequent written and oral
forward-looking statements concerning XpresSpa Group, or other
matters and attributable to XpresSpa Group or any person acting on
its behalf are expressly qualified in their entirety by the
cautionary statements above. XpresSpa Group does not undertake any
obligation to publicly update any of these forward-looking
statements to reflect events or circumstances that may arise after
the date hereof.
Media - XpresSpaJulie Ferguson
Julie@jfprmedia.com(312) 385-0098
Investor Relations -
XpresSpaICRRaphael Gross(203) 682-8253
XpresSpa (NASDAQ:XSPA)
Historical Stock Chart
From Feb 2024 to Mar 2024
XpresSpa (NASDAQ:XSPA)
Historical Stock Chart
From Mar 2023 to Mar 2024